Biophysicist Targets Protein As a Way to Stop Breast, Prostate Cancer

by Savitha C Muppala on  April 23, 2011 at 5:23 PM Cancer News   - G J E 4
An Ohio State biophysicist is putting his effort on a protein molecule Interleukin-6 (IL-6) to stop breast and prostate cancer.
 Biophysicist Targets Protein As a Way to Stop Breast, Prostate Cancer
Biophysicist Targets Protein As a Way to Stop Breast, Prostate Cancer

Chenglong Li, used a supercomputer to search thousands of molecular combinations for the best configuration to block a protein that can cause breast or prostate cancer.

Li Is leveraging a powerful computer cluster at the Ohio Supercomputer Center (OSC) to develop a drug that will block the small protein molecule Interleukin-6 (IL-6).

The body normally produces this immune-response messenger to combat infections, burns, traumatic injuries, etc. Scientists have found, however, that in people who have cancer, the body fails to turn off the response and overproduces IL-6.

Based on the a series of investigations into IL-6 in the past to synthesize effective cancer drugs, Li recognized the potential of those initial insights and partnered last year with an organic chemist and a cancer biologist at OSU's James Cancer Hospital to further investigate, using an OSC supercomputer to construct malleable, three-dimensional color simulations of the protein complex.

"We proposed using computational intelligence to re-engineer a new set of compounds that not only preserve the original properties, but also would be more potent and efficient," Li said.

"Our initial feasibility study pointed to compounds with a high potential to be developed into a non-toxic, orally available drug," he added.While we didn't promise to have a drug fully developed within the two years of the project, we're making excellent progress," said Li.

"The current research offers us an exciting new therapeutic paradigm: targeting tumour microenvironment and inhibiting tumour stem cell renewal, leading to a really effective way to overcome breast tumour drug resistance, inhibiting tumour metastasis and stopping tumour recurrence," added Li.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like